WHO ICTRP trial
Direct effect of four different compounds on experimental pain
EUCTR2011-000291-34-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2011-000291-34-NL |
|---|---|
| Public title | Direct effect of four different compounds on experimental pain |
| Scientific title | Direct effect of four different compounds on experimental pain |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Netherlands |
| Conditions | experimental pain |
| Interventions | Product Name: Adenoscan Product Code: na Pharmaceutical Form: Intravenous infusion Pharmaceutical form of the placebo: Intravenous infusion Route of administration of the placebo: Intravenous use Product Name: zoledronic acid Product Code… |
| Registration date | Feb 18, 2011 |
| Target size | 48 |
| Secondary IDs | 20101108 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: